Data-driven Drug Discovery in Women’s Health & Reproductive Medicine | Kisaco Research
  • Discover how real-world data, genomics, and AI are revealing new targets and mechanisms in female-specific and reproductive conditions.
  • Learn how data integration is shortening timelines from target identification to preclinical validation.
  • Sharing insights into novel drug discovery approaches, the use of AI, multi-omics data, and 3D models.
Session Topics: 
Reproductive Health
Speaker(s): 

Author:

Stasa Stankovic

Chief Executive Officer
Ovartix

Stasa Stankovic

Chief Executive Officer
Ovartix
Session Job Focus: 
Time: 
4:00 PM - 4:30 PM
Agenda Track No.: 
Track 7
Session Type: 
Track